Skip to Content

Largo Hospital first on Florida's west coast to perform innovative cardiovascular procedure

Tricuspid regurgitation affects 1.6 million people in the United States every year. Severe tricuspid regurgitation can ultimately lead to end-organ damage and right-side heart failure.

June 17, 2024
Patient Lucien Bouchard and Dr. Saurabh Sanon after successful transcatheter tricuspid valve repair

Largo, FL  HCA Florida Largo Hospital is the first on the West Coast of Florida to successfully perform an innovative procedure for a patient affected by severe tricuspid regurgitation. Tricuspid regurgitation is a valve disease in which the valve between the two right-sided heart chambers does not close properly. It affects 1.6 million people in the United States every year. Severe tricuspid regurgitation can ultimately lead to end-organ damage and right-side heart failure.  

Transcatheter tricuspid valve repair using the repair system is a new structural heart procedure for patients with severe tricuspid valve regurgitation, which was approved by the U.S. Food and Drug Administration in April 2024. Historically, the only options for these patients would be open-heart surgery and if the patient was not a surgical candidate, symptoms would be managed by medications.  

Dr. Saurabh Sanon, Dr. Stephanie Kemp and Dr. Chittoor B Sai Sudhaker led the cardiovascular cath lab team at HCA Florida Largo Hospital in performing this innovative procedure that will now expand treatment opportunities for this patient population.

Patient Lucien Bouchard, an 87-year-old male, had severe tricuspid regurgitation and was experiencing dizziness, fatigue, shortness of breath with activity and lower extremity swelling. Dr. Sanon and team utilized this minimally invasive option that is uniquely designed to repair the leaky valve without the need for open-heart surgery.

"I am thrilled to announce our team's first commercial transcatheter tricuspid valve repair procedure. This breakthrough procedure signifies a major leap forward in treating tricuspid valve regurgitation and has the potential to offer new minimally invasive treatment options for a wider range of patients suffering from this condition", shared Dr. Saurabh Sanon, Structural Interventional Cardiologist and Regional Medical Director of Structural Heart Therapies for West Florida Division of HCA Florida Healthcare. 

At HCA Florida Largo Hospital, we serve as a regional referral center for patients with heart disease.  I am incredibly proud of our team and how they consistently bring the best and most advanced treatment options to our patients right here in West Florida,” shared Dr. Sebastian Strom, CEO of HCA Florida Largo Hospital.

Published:
June 17, 2024
Location:
HCA Florida Largo Hospital

Related Newsroom Articles


HCA Florida Largo Hospital achieves another first with Dual Chamber Leadless Pacemaker implant 
July 15, 2024
This new technology offers beat-to-beat communication between the two leadless pacemakers, which synchronizes the upper and lower chambers.

HCA Florida Largo Hospital achieves another first with Dual Chamber Leadless Pacemaker implant 
July 15, 2024
This new technology offers beat-to-beat communication between the two leadless pacemakers, which synchronizes the upper and lower chambers.

HCA Florida Healthcare Hospitals named to Healthgrades America's 250 Best Hospitals 
January 25, 2024
Several HCA Florida Healthcare hospitals are proud to be recognized for the continued commitment to positive patient outcomes.

HCA Florida Largo Hospital First in Florida to Perform Innovative Cardiovascular Procedure 
December 12, 2023
Dr. Saurabh Sanon led the cardiovascular cath lab team in performing what is called the SEATTLE procedure, which is an acronym for The Simplified Extraction of Atrial Tumor with Targeted Loop Electricity.